{"pub": "washingtontimes", "url": "https://washingtontimes.com/news/2019/sep/30/cvs-stops-sale-of-heartburn-drugs-with-suspect-con", "downloaded_at": "2019-10-01 00:16:47.057877+00:00", "title": "CVS stops sale of Zantac, store generic heartburn drug with suspect contaminant", "language": "en", "text": "CVS has halted sales of popular heartburn treatment Zantac and the store generic version after warnings by U.S. health regulators.\n\nCVS is the latest retailer to pull the heartburn tablets from store shelves. Earlier this month, the U.S. Food and Drug Administration warned consumers about a potentially dangerous contaminant in prescription and over-the-counter versions of Zantac.\n\nIn its announcement this weekend, CVS said customers who bought Zantac products can return them for a refund. The retailer will continue to sell other heartburn medications such as Pepcid.\n\nSome manufacturers of the drug have stopped distribution. Health officials say concerned patients should consult their doctor.\n\nSign up for Daily Newsletters\n\nCopyright \u00a9 2019 The Washington Times, LLC.", "description": "CVS has halted sales of popular heartburn treatment Zantac and the store generic version after warnings by U.S. health regulators.", "authors": ["The Washington Times Http"], "top_image": "https://twt-thumbs.washtimes.com/media/image/2019/09/30/Contaminated_Drugs_Heartburn_87951.jpg-36054_c0-0-3736-2178_s1770x1032.jpg?ca55922aec28163bb924cdac1fc419b35b664f0c", "published_at": "2019-09-30"}